Chargement en cours...
Cisplatin treatment increases stemness through upregulation of hypoxia‐inducible factors by interleukin‐6 in non‐small cell lung cancer
Cisplatin‐resistant A549 and H157 (A549CisR and H157CisR) non‐small cell lung cancer cells show increased stemness of cancer stem cells (CSCs) compared to their parental cells. We investigated whether interleukin‐6 (IL‐6) signaling contributes to this increased stemness in cisplatin‐resistant cells....
Enregistré dans:
| Publié dans: | Cancer Sci |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4968604/ https://ncbi.nlm.nih.gov/pubmed/27009878 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12937 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|